Home > SANTE - SCIENCES DE LA VIE > Biotechnologies Et Génétique > Carbohydrate Therapeutics IRCD
AUTRES RESSOURCES
 
AUTRES SECTEURS
 
TOUS NOS SECTEURS
 
Biotechnologies Et Génétique > Etude de marché sectorielle
 Carbohydrate Therapeutics IRCD
€ 1 200,00
Editeur :
ZZZ - Biovista
Langue :
Anglais
Date de publication :
Juillet 2001
Taille du document :
N/A
Autres informations :
Description , Table des matières
 
Recevez cette publication aujourd'hui !
Price : EUR 1 200,00
Plus d'information ?
+33 437 37 1637
 
Rechercher d'autres rapports et études à commander

Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux


Rapports privés en relation
Pharmacogenomics
160 pages | Décembre 2000 |
The Human Genome Project and numerous corporate and academic human gene sequencing efforts have revealed, among others, that genes exist in the population in numerous mutated forms, some of which
1 400,00 €
 
 
The Genomics Outlook To 2005: Transforming pharmaceutical and diagnostic markets
150 pages | Janvier 2002 |
Genomics is quietly transforming the pharmaceutical industry.
Companies are moving from medicinal chemistry based drug discovery and development, to using information provided by genomics.
V
953,48 €
 
 
05-001: Improving Sales Rep Performance: A Global Analysis
219 pages | Janvier 2005 |
This report is designed to offer insights on how sales executives can align their sales force organization, recruitment and training in a way that reflects the needs and expectations of scientific cus
1 520,00 €
 
 
Bioinformatics
150 pages | Décembre 2000 |
Automation has assaulted several levels of biological research generating vast amounts of data.
Great leaps in DNA sequencing technology and automation led to a dramatic increase in sequence th
1 400,00 €
 
 
03-054: Immunohistochemistry Market Benchmarking Survey
90 pages | Octobre 2003 |
This report provides an overview of the most commonly used methods and products for tissue/sample preparation and antigen detection to help suppliers understand researchers’ experiences, preferences a
680,00 €
 
 
Combinatorics
150 pages | Décembre 2000 |
Identified by The Economist (*) as the industry to watch for 1997 in the chemicals sector, Combinatorics (also known as combinatorial chemistry) is an emerging platform technology that uses test t
1 400,00 €
 
 
DNA Sequencing and PCR Markets
252 pages | Novembre 2004 |
The focus of this report is to describe the specific segment of the life sciences market called DNA sequencing.
This analysis includes all of the generally accepted DNA-oriented analytical activiti
2 800,00 €
 
 
03-019: The Market for Microbial Genotyping Products: Research and Testing Applications
183 pages | Juin 2003 |
The report identifies the kits, reagents and instrumentation that are most commonly used for microbial identification and analysis in both the research and testing arenas
800,00 €
 
 
Biogenerics: Challenges and Promise
154 pages | Janvier 2005 |
Biogenerics: Challenges and Promise takes an insightful look at the burgeoning biogenerics industry and helps to clarify the complicated regulations that currently govern biogeneric development in bot
799,20 €
 
 
Carbohydrate Therapeutics IRCD
pages | Juillet 2001 |
Carbohydrates are the only class of biological molecule (there are four main classes: nucleic acids, proteins, lipids, and carbohydrates - commonly known as sugars), that can be found in direct associ
1 200,00 €
 
 
 
Autres secteurs en relation
Rechercher d'autres rapports!
 
 
 
Présentation de l'étude de marché - Description & Table des matières
 Carbohydrate Therapeutics IRCD

Carbohydrates are the only class of biological molecule (there are four main classes:
 
nucleic acids, proteins, lipids, and carbohydrates - commonly known as sugars),
 
that can be found in direct association with all three of the rest. Nucleic acids
 
have a sugar building block, there are glycoproteins and also proteoglycans, and
 
finally, there are also glycolipids.
 

Carbohydrates are found throughout a cell's critical areas, or in association
 
with molecules that float throughout the body, such as serum proteins. The reason
 
is that they enable specific recognition to take place between molecules, by
 
providing a unique molecular address that takes the form of distinct shape and
 
charge characteristics. Carbohydrates are involved in most, if not all, forms
 
of molecular recognition because of the ability of this particular type of molecule
 
to form a multitude of structures, far in excess of what the other principal
 
biological building blocks, or monomers, can do.


 

Carbohydrate monomer building blocks are extremely diverse, and can be linked
 
together in a multitude of ways, forming linear or branched structures. Five
 
sugar monomers can give rise to 32 million different compounds, whereas five
 
amino acids can produce 120 chains only.


 

I) KNOWLEDGE BLOCK 1: TECHNOLOGY SUMMARY

A) Background

B) Development Issues

C) Biochip Examples

II) KNOWLEDGE BLOCK 2: BUSINESS DEVELOPMENT

A) Platform Biotechnologies

B) Current Conditions

III )KNOWLEDGE BLOCK 3: COMPANY DATABASE

A) Methodology

B) Concise Company Listing

C) Extended Company Listing

IV) KNOWLEDGE BLOCK 4: PATENTS DATABASE

A) Methodology

B) Concise Patent Listing

C) Extended Patent Listing


New Search:

PPLSEN